Published in J Neurosci Res on January 01, 2009
Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats. Crit Care Med (2012) 1.60
Inflammation, cerebral vasospasm, and evolving theories of delayed cerebral ischemia. Neurol Res Int (2013) 0.89
Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm. J Cardiovasc Pharmacol (2013) 0.88
Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage. Stroke (2011) 0.87
Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhage. Br J Pharmacol (2012) 0.85
Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage. Neurocrit Care (2010) 0.84
Regulation of microRNAs miR-30a and miR-143 in cerebral vasculature after experimental subarachnoid hemorrhage in rats. BMC Genomics (2015) 0.83
To look beyond vasospasm in aneurysmal subarachnoid haemorrhage. Biomed Res Int (2014) 0.83
Intravenous infusion of magnesium chloride improves epicenter blood flow during the acute stage of contusive spinal cord injury in rats. J Neurotrauma (2013) 0.83
Description of the vasospasm phenomena following perimesencephalic nonaneurysmal subarachnoid hemorrhage. Biomed Res Int (2013) 0.82
Toll-like Receptor 4 (TLR4) is Associated with Cerebral Vasospasm and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage. Neurol Med Chir (Tokyo) (2015) 0.80
Innovative approach for prevention and treatment of post subarachnoid hemorrhage vasospasm: A preliminary report. Asian J Neurosurg (2012) 0.80
Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. BMC Neurol (2011) 0.80
Endocannabinoids in cerebrovascular regulation. Am J Physiol Heart Circ Physiol (2016) 0.79
Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries. J Cereb Blood Flow Metab (2010) 0.78
Glycyrrhizin attenuates Toll like receptor-2, -4 and experimental vasospasm in a rat model. J Immunol Res (2014) 0.78
Correlation between plasma total nitric oxide levels and cerebral vasospasm and clinical outcome in patients with aneurysmal subarachnoid hemorrhage in Indian population. J Neurosci Rural Pract (2014) 0.77
A hypothesis: hydrogen sulfide might be neuroprotective against subarachnoid hemorrhage induced brain injury. ScientificWorldJournal (2014) 0.77
The Role of Circulating Tight Junction Proteins in Evaluating Blood Brain Barrier Disruption following Intracranial Hemorrhage. Dis Markers (2015) 0.77
IL-33 expression in the cerebral cortex following experimental subarachnoid hemorrhage in rats. Cell Mol Neurobiol (2014) 0.76
Novel insights into the delayed vasospasm following subarachnoid haemorrhage: importance of proteinase signalling. Br J Pharmacol (2012) 0.75
Valproic acid attenuates intercellular adhesion molecule-1 and E-selectin through a chemokine ligand 5 dependent mechanism and subarachnoid hemorrhage induced vasospasm in a rat model. J Inflamm (Lond) (2015) 0.75
CaMKII inhibition with KN93 attenuates endothelin and serotonin receptor-mediated vasoconstriction and prevents subarachnoid hemorrhage-induced deficits in sensorimotor function. J Neuroinflammation (2014) 0.75
Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model. Biomed Res Int (2015) 0.75
Role of CT perfusion imaging in the diagnosis and treatment of vasospasm. Imaging Med (2011) 0.75
Cerebral vasospasm affects arterial critical closing pressure. J Cereb Blood Flow Metab (2014) 0.75
Delayed Vasospasm after Aneurysmal Subarachnoid Hemorrhage in Behcet Syndrome. J Cerebrovasc Endovasc Neurosurg (2016) 0.75
Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. J Neurosurg (2010) 1.53
S100B in neuropathologic states: the CRP of the brain? J Neurosci Res (2007) 1.39
Temporal window of metabolic brain vulnerability to concussions: mitochondrial-related impairment--part I. Neurosurgery (2007) 1.35
Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol (2003) 1.14
When a minor head injury results in enduring symptoms: a prospective investigation of risk factors for postconcussional syndrome after mild traumatic brain injury. J Neurol Neurosurg Psychiatry (2011) 1.12
Temporal window of metabolic brain vulnerability to concussions: oxidative and nitrosative stresses--part II. Neurosurgery (2007) 1.09
Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clin Biochem (2009) 1.07
Is aspect ratio a reliable predictor of intracranial aneurysm rupture? Neurosurgery (2004) 1.06
Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med (2015) 0.96
Transient alterations of creatine, creatine phosphate, N-acetylaspartate and high-energy phosphates after mild traumatic brain injury in the rat. Mol Cell Biochem (2009) 0.96
Primary decompressive craniectomy for acute subdural haematomas: results of an international survey. Acta Neurochir (Wien) (2012) 0.94
Transcriptomics of traumatic brain injury: gene expression and molecular pathways of different grades of insult in a rat organotypic hippocampal culture model. J Neurotrauma (2010) 0.91
Placement of silicone sheeting at decompressive craniectomy to prevent adhesions at cranioplasty. Br J Neurosurg (2010) 0.89
Brain 'imaging' in the Renaissance. J R Soc Med (2007) 0.85
Decrease in N-acetylaspartate following concussion may be coupled to decrease in creatine. J Head Trauma Rehabil (2013) 0.84
Extracellular N-acetylaspartate depletion in traumatic brain injury. J Neurochem (2005) 0.84
Autologous cranioplasty following decompressive craniectomy in the trauma setting. Br J Neurosurg (2014) 0.83
Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report. World J Surg (2004) 0.83
Potentially neuroprotective gene modulation in an in vitro model of mild traumatic brain injury. Mol Cell Biochem (2012) 0.83
Proposal for establishment of the UK Cranial Reconstruction Registry (UKCRR). Br J Neurosurg (2013) 0.81
Mitochondrial DNA and traumatic brain injury. Ann Neurol (2014) 0.80
Post-traumatic head injury pituitary dysfunction. Disabil Rehabil (2012) 0.79
Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA). J Neurotrauma (2014) 0.77
The role of vagus nerve overactivity in the increased incidence of pneumonia following traumatic brain injury. Br J Neurosurg (2013) 0.76
S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury. Neurochem Res (2015) 0.76
Nimodipine for traumatic [corrected] subarachnoid haemorrhage: the end of the road or better trials? Lancet Neurol (2006) 0.75
Post-traumatic Spinal Hygroma Causing Cord Compression in type III Odontoid fracture with Vertical Atlanto-Axial Instability. Spine (Phila Pa 1976) (2017) 0.75
Post-traumatic Spinal Hygroma Causing Cord Compression in Type III Odontoid Fracture With Vertical Atlantoaxial Instability. Spine (Phila Pa 1976) (2017) 0.75
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol (2017) 0.75
Endotheliopathy of Trauma is an On-Scene Phenomenon, and is Associated with Multiple Organ Dysfunction Syndrome: A Prospective Observational Study. Shock (2017) 0.75